Australian and New Zealand Children’s Haematology/Oncology Group (ANZCHOG) Scientific Meeting

Eadie, L. (Participant)

Acute Lymphoblastic Leukaemia Group

Activity: Other

Description

Tavakoli PS, Eadie LN, Heatley SL, White DL.
The dual SYK/JAK inhibitor cerdulatinib demonstrates in vitro efficacy against a novel MYB-TYK2 fusion protein in acute lymphoblastic leukaemia cells.
Oral Presentation
Christchurch, New Zealand

Period	13 Jun 2019 → 15 Jun 2019